BROMPHENIRAMINE MALEATE

Post-LOE

brompheniramine maleate

ANDAORALTABLET

Approved

Aug 1978

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

1

Indications (5)

nasal congestion due to the common cold hay fever other upper respiratory allergies temporarily relieves these symptoms due to hay fever (allergic rhinitis) runny nose itchy watery eyes sneezing itching of the nose throat temporarily restores freer breathing through the nose

Clinical Trials (1)

NCT00894634Phase 1Completed

Study Evaluating Brompheniramine Maleate Liquid in Children and Adolescents

Started Mar 2009

37 enrolled

Allergic Reactions

Company

CA - San Francisco

External Resources

Full prescribing information

FDA approval history

Drug nomenclature & identifiers